| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucokinase activity | 2.31e-04 | 5 | 97 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 2.31e-04 | 5 | 97 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 2.31e-04 | 5 | 97 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 4.83e-04 | 7 | 97 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | rRNA binding | 5.95e-04 | 79 | 97 | 4 | GO:0019843 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 8.22e-04 | 9 | 97 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF22 ZNF676 SATB1 PER2 SUZ12 ZNF99 | 9.46e-04 | 1244 | 97 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF22 ZNF676 SATB1 PER2 SUZ12 ZNF99 | 1.17e-03 | 1271 | 97 | 15 | GO:0000987 |
| GeneOntologyCellularComponent | hemidesmosome | 1.51e-05 | 11 | 96 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.02e-04 | 443 | 96 | 9 | GO:0030055 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 TRIT1 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 SUZ12 ZNF99 | 2.17e-08 | 777 | 99 | 19 | PS00028 |
| Domain | - | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 ZNF99 | 9.48e-08 | 679 | 99 | 17 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 SUZ12 ZNF99 | 1.17e-07 | 775 | 99 | 18 | PS50157 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 ZNF99 | 1.29e-07 | 694 | 99 | 17 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 SUZ12 ZNF99 | 1.74e-07 | 796 | 99 | 18 | IPR015880 |
| Domain | Znf_C2H2 | ZNF729 TRIT1 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 ZNF99 | 2.05e-07 | 805 | 99 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 CREB5 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 SUZ12 ZNF99 | 2.17e-07 | 808 | 99 | 18 | SM00355 |
| Domain | zf-C2H2 | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 ZNF99 | 6.97e-07 | 693 | 99 | 16 | PF00096 |
| Domain | Liprin | 2.86e-06 | 6 | 99 | 3 | IPR029515 | |
| Domain | SAM_DOMAIN | 1.13e-05 | 95 | 99 | 6 | PS50105 | |
| Domain | SAM | 1.27e-05 | 97 | 99 | 6 | IPR001660 | |
| Domain | - | 2.12e-05 | 106 | 99 | 6 | 1.10.150.50 | |
| Domain | SAM_1 | 3.02e-05 | 68 | 99 | 5 | PF00536 | |
| Domain | SAM/pointed | 3.70e-05 | 117 | 99 | 6 | IPR013761 | |
| Domain | NPIP | 5.04e-05 | 14 | 99 | 3 | IPR009443 | |
| Domain | SAM_2 | 7.82e-05 | 43 | 99 | 4 | PF07647 | |
| Domain | Zfx_Zfy_act | 8.32e-05 | 3 | 99 | 2 | PF04704 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 8.32e-05 | 3 | 99 | 2 | IPR006794 | |
| Domain | SAM | 1.05e-04 | 88 | 99 | 5 | SM00454 | |
| Domain | zf-C2H2_6 | 2.65e-04 | 314 | 99 | 8 | PF13912 | |
| Domain | Hexokinase_C | 2.75e-04 | 5 | 99 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 2.75e-04 | 5 | 99 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 2.75e-04 | 5 | 99 | 2 | PF00349 | |
| Domain | Hexokinase_2 | 2.75e-04 | 5 | 99 | 2 | PF03727 | |
| Domain | HEXOKINASE_2 | 2.75e-04 | 5 | 99 | 2 | PS51748 | |
| Domain | Hexokinase_BS | 2.75e-04 | 5 | 99 | 2 | IPR019807 | |
| Domain | HEXOKINASE_1 | 2.75e-04 | 5 | 99 | 2 | PS00378 | |
| Domain | Hexokinase | 4.11e-04 | 6 | 99 | 2 | IPR001312 | |
| Domain | Kinase-like_dom | 2.34e-03 | 542 | 99 | 9 | IPR011009 | |
| Domain | S_TKc | 3.00e-03 | 359 | 99 | 7 | SM00220 | |
| Domain | SH3 | 5.87e-03 | 216 | 99 | 5 | PS50002 | |
| Domain | Znf_C2H2_jaz | 6.00e-03 | 22 | 99 | 2 | IPR022755 | |
| Pubmed | GTPBP4 STAM2 HK1 MRPL10 GPAT3 CLASP2 ME2 ERBIN LARP7 DNAJC2 MRPS7 SYNE2 UBA6 OCIAD2 TTC17 DDHD2 LAS1L MAP2K1 USP48 DDX24 GOLGB1 | 1.51e-09 | 1487 | 101 | 21 | 33957083 | |
| Pubmed | 6.56e-08 | 14 | 101 | 4 | 20095854 | ||
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 9.49e-08 | 4 | 101 | 3 | 18055785 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GTPBP4 HK1 HK2 MRPL10 GPAT3 DYNC2I1 LARS2 ME2 MRPS7 DST SYNE2 OCIAD2 ACSF3 TTC17 DDHD2 LAS1L DDX24 GOLGB1 | 2.87e-07 | 1496 | 101 | 18 | 32877691 |
| Pubmed | SETX TRIP6 ARHGAP10 MAP3K20 CLASP2 ECT2 ERBIN LARP7 DNAJC2 CCNT1 MRPS7 DST ACAD11 METTL18 TPX2 SUZ12 LAS1L GOLGB1 | 2.90e-07 | 1497 | 101 | 18 | 31527615 | |
| Pubmed | 4.40e-07 | 234 | 101 | 8 | 36243803 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX HK2 ARHGAP10 ACLY REV3L ECT2 CREB5 LARP7 PRDM10 SATB1 TPX2 DDX24 ANKRD26P1 | 1.25e-06 | 857 | 101 | 13 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STAM2 HIVEP1 SETX TRIP6 MAP3K20 CLASP2 STK32C ECT2 ERBIN DST SYNE2 MAP2K1 GOLGB1 | 1.32e-06 | 861 | 101 | 13 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ARHGAP10 PPFIBP2 PPFIA2 DYNC2I1 CLASP2 STK32C ME2 ERBIN ZNF462 RAB28 ZNF827 EXOC6B UBA6 ACSF3 TTC17 LRBA GOLGB1 | 1.32e-06 | 1489 | 101 | 17 | 28611215 |
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 2.74e-06 | 134 | 101 | 6 | 28695742 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.23e-06 | 410 | 101 | 9 | 26949251 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 5.13e-06 | 12 | 101 | 3 | 9624153 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 7.52e-06 | 92 | 101 | 5 | 15840729 | |
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 8.35e-06 | 2 | 101 | 2 | 1691708 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8188262 | ||
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 8.35e-06 | 2 | 101 | 2 | 2497060 | |
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 8.35e-06 | 2 | 101 | 2 | 2041734 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8318216 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2105457 | ||
| Pubmed | Genetic heterogeneity within a consanguineous family involving TTPA and SETX genes. | 8.35e-06 | 2 | 101 | 2 | 38109176 | |
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 8.35e-06 | 2 | 101 | 2 | 38602753 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12716983 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 8.35e-06 | 2 | 101 | 2 | 9126493 | |
| Pubmed | Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. | 8.35e-06 | 2 | 101 | 2 | 19329779 | |
| Pubmed | Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs. | 8.35e-06 | 2 | 101 | 2 | 1970799 | |
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 8.35e-06 | 2 | 101 | 2 | 8487630 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24990892 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2308929 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28251288 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21504994 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 34324278 | ||
| Pubmed | Zfx mutation results in small animal size and reduced germ cell number in male and female mice. | 8.35e-06 | 2 | 101 | 2 | 9187153 | |
| Pubmed | DDX24 promotes tumor progression by mediating hexokinase-1 induced glycolysis in gastric cancer. | 8.35e-06 | 2 | 101 | 2 | 38043669 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2265557 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 SETX HK1 HK2 TRIP6 ACLY MAP3K20 ECT2 ERBIN CCNT1 MRPS7 DST LAS1L DDX24 RPL19 | 8.44e-06 | 1353 | 101 | 15 | 29467282 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 HIVEP1 SETX ZNF462 CCNT1 SATB1 TPX2 SUZ12 USP48 DDX24 | 1.14e-05 | 608 | 101 | 10 | 36089195 |
| Pubmed | 1.26e-05 | 486 | 101 | 9 | 20936779 | ||
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 1.30e-05 | 16 | 101 | 3 | 16096065 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.64e-05 | 183 | 101 | 6 | 31932471 | |
| Pubmed | 2.08e-05 | 191 | 101 | 6 | 31177093 | ||
| Pubmed | 2.11e-05 | 653 | 101 | 10 | 22586326 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.48e-05 | 197 | 101 | 6 | 20811636 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26855992 | ||
| Pubmed | Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. | 2.50e-05 | 3 | 101 | 2 | 21430642 | |
| Pubmed | Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2. | 2.50e-05 | 3 | 101 | 2 | 30871777 | |
| Pubmed | Zfy gene expression patterns are not compatible with a primary role in mouse sex determination. | 2.50e-05 | 3 | 101 | 2 | 2480529 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12479614 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27293546 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11299520 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16931773 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32406922 | ||
| Pubmed | Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease. | 2.50e-05 | 3 | 101 | 2 | 33525649 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19049977 | ||
| Pubmed | Nek10 mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation. | 2.50e-05 | 3 | 101 | 2 | 20956560 | |
| Pubmed | Isolation of monochromosomal hybrids for mouse chromosomes 3, 6, 10, 12, 14, and 18. | 2.50e-05 | 3 | 101 | 2 | 9060403 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 38310188 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 20347420 | ||
| Pubmed | YAC clone contigs surrounding the Zfx and Pola loci on the mouse X chromosome. | 2.50e-05 | 3 | 101 | 2 | 8406471 | |
| Pubmed | c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. | 2.50e-05 | 3 | 101 | 2 | 28054552 | |
| Pubmed | 3.83e-05 | 560 | 101 | 9 | 35241646 | ||
| Pubmed | GTPBP4 MRPL10 CLASP2 LARP7 CCNT1 MRPS7 ZNF22 ACAD11 DDX24 RPL19 | 4.43e-05 | 713 | 101 | 10 | 29802200 | |
| Pubmed | 4.83e-05 | 222 | 101 | 6 | 37071664 | ||
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 4.99e-05 | 4 | 101 | 2 | 25904018 | |
| Pubmed | Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. | 4.99e-05 | 4 | 101 | 2 | 23962723 | |
| Pubmed | ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. | 4.99e-05 | 4 | 101 | 2 | 24485662 | |
| Pubmed | Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion. | 4.99e-05 | 4 | 101 | 2 | 20683478 | |
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 4.99e-05 | 4 | 101 | 2 | 25766729 | |
| Pubmed | Zfx controls the self-renewal of embryonic and hematopoietic stem cells. | 4.99e-05 | 4 | 101 | 2 | 17448993 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 24789282 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11375975 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 32152094 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 GTPBP4 HK2 TRIP6 ACLY PBK CLASP2 DNAJC2 MRPS7 SYNE2 UBA6 DDX24 GOLGB1 RPL19 | 5.99e-05 | 1415 | 101 | 14 | 28515276 |
| Pubmed | GTPBP4 HIVEP1 TRIP6 MRPL10 ERBIN ZNF462 MRPS7 DST SATB1 SYNE2 TPX2 LAS1L DDX24 RPL19 | 6.66e-05 | 1429 | 101 | 14 | 35140242 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 7.44e-05 | 759 | 101 | 10 | 35915203 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | TRIT1 HK1 HK2 ACLY MRPL10 LARS2 ME2 MRPS7 ACAD11 SFXN2 ACSF3 | 8.07e-05 | 926 | 101 | 11 | 20877624 |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 9244432 | ||
| Pubmed | Chromosome mapping and expression of a putative testis-determining gene in mouse. | 8.30e-05 | 5 | 101 | 2 | 2563174 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 9721210 | ||
| Pubmed | Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway. | 8.30e-05 | 5 | 101 | 2 | 25164012 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 19013515 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 15574336 | ||
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 8.30e-05 | 5 | 101 | 2 | 7681608 | |
| Pubmed | Structure and function of hemidesmosomes: more than simple adhesion complexes. | 8.30e-05 | 5 | 101 | 2 | 10201522 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 27991921 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 STAM2 ACLY ME2 ERBIN CCNT1 DST TPX2 LRBA GOLGB1 RPL19 | 8.71e-05 | 934 | 101 | 11 | 33916271 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ROCK2 GTPBP4 TRIP6 ACLY CLASP2 ODC1 MRPS7 TTBK1 LRBA BCAR3 LAS1L MED7 DDX24 | 8.93e-05 | 1284 | 101 | 13 | 17353931 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 9.13e-05 | 361 | 101 | 7 | 26167880 | |
| Pubmed | 9.89e-05 | 634 | 101 | 9 | 34591612 | ||
| Pubmed | 1.04e-04 | 497 | 101 | 8 | 23414517 | ||
| Pubmed | 1.13e-04 | 645 | 101 | 9 | 25281560 | ||
| Pubmed | 1.13e-04 | 503 | 101 | 8 | 16964243 | ||
| Pubmed | 1.18e-04 | 506 | 101 | 8 | 30890647 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 7821804 | ||
| Pubmed | An EB1-binding motif acts as a microtubule tip localization signal. | 1.24e-04 | 6 | 101 | 2 | 19632184 | |
| Pubmed | Subunit composition of the human cytoplasmic dynein-2 complex. | 1.24e-04 | 6 | 101 | 2 | 25205765 | |
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 1.24e-04 | 6 | 101 | 2 | 21618221 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 28431135 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 18281698 | ||
| Pubmed | RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation. | 1.24e-04 | 6 | 101 | 2 | 20562857 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ROCK2 HK1 TRIP6 ITGA6 ME2 ERBIN ZNF22 SYNE2 UBA6 OCIAD2 DDX24 GOLGB1 RPL19 | 1.66e-04 | 1367 | 101 | 13 | 32687490 |
| Interaction | CCDC140 interactions | 1.90e-06 | 117 | 100 | 7 | int:CCDC140 | |
| Interaction | ZBTB47 interactions | 7.55e-06 | 144 | 100 | 7 | int:ZBTB47 | |
| Interaction | SRP14 interactions | GTPBP4 ZBTB48 ZNF317 LARP7 MRPS7 ZNF22 METTL18 USP48 DDX24 RPL19 | 1.40e-05 | 366 | 100 | 10 | int:SRP14 |
| Interaction | KRR1 interactions | GTPBP4 LARP7 ZFX MRPS7 ZNF22 PRDM10 SUZ12 MAP2K1 DDX24 RPL19 | 1.89e-05 | 379 | 100 | 10 | int:KRR1 |
| Interaction | EPHA1 interactions | 2.25e-05 | 235 | 100 | 8 | int:EPHA1 | |
| Interaction | GLI4 interactions | 3.74e-05 | 125 | 100 | 6 | int:GLI4 | |
| Interaction | H1-1 interactions | GTPBP4 ZBTB48 ARHGAP10 REV3L ECT2 LARP7 ZNF22 PRDM10 SUZ12 USP48 DDX24 | 4.31e-05 | 507 | 100 | 11 | int:H1-1 |
| Interaction | OPTN interactions | 4.71e-05 | 422 | 100 | 10 | int:OPTN | |
| Interaction | PPAN interactions | 5.00e-05 | 193 | 100 | 7 | int:PPAN | |
| Interaction | RPL26L1 interactions | GTPBP4 ZBTB48 ZNF317 ECT2 LARP7 DNAJC2 MRPS7 ZNF22 DDX24 RPL19 | 5.62e-05 | 431 | 100 | 10 | int:RPL26L1 |
| Interaction | H2AB3 interactions | 5.99e-05 | 136 | 100 | 6 | int:H2AB3 | |
| Interaction | HNRNPCL2 interactions | 6.66e-05 | 274 | 100 | 8 | int:HNRNPCL2 | |
| Interaction | NPM1 interactions | ROCK2 GTPBP4 HIVEP1 ZBTB48 MRPL10 NEB ECT2 LARP7 DNAJC2 CCNT1 ZNF22 PRDM10 SYNE2 SUZ12 LAS1L DDX24 RPL19 | 8.13e-05 | 1201 | 100 | 17 | int:NPM1 |
| Interaction | MACROH2A2 interactions | 8.77e-05 | 211 | 100 | 7 | int:MACROH2A2 | |
| Interaction | EZH1 interactions | 9.50e-05 | 92 | 100 | 5 | int:EZH1 | |
| Interaction | YBX2 interactions | 9.65e-05 | 289 | 100 | 8 | int:YBX2 | |
| Interaction | RPS6 interactions | ROCK2 GTPBP4 ECT2 LARP7 DNAJC2 MRPS7 ZNF22 PRDM10 TPX2 LAS1L MAP2K1 DDX24 GOLGB1 RPL19 | 1.03e-04 | 874 | 100 | 14 | int:RPS6 |
| Interaction | H1-2 interactions | ZBTB48 REV3L NEB LARP7 ZNF22 PRDM10 DST XRRA1 SUZ12 MAP2K1 USP48 DDX24 | 1.13e-04 | 666 | 100 | 12 | int:H1-2 |
| Interaction | SRSF5 interactions | GTPBP4 ECT2 LARP7 MRPS7 ZNF22 PRDM10 SUZ12 MAP2K1 DDX24 RPL19 | 1.23e-04 | 474 | 100 | 10 | int:SRSF5 |
| Interaction | RPL7A interactions | GTPBP4 ZNF317 ECT2 LARP7 DNAJC2 ZNF22 PRDM10 SYNE2 MAP2K1 USP48 DDX24 RPL19 | 1.36e-04 | 679 | 100 | 12 | int:RPL7A |
| Interaction | ZBTB48 interactions | 1.37e-04 | 158 | 100 | 6 | int:ZBTB48 | |
| Interaction | RPL36AL interactions | 1.53e-04 | 309 | 100 | 8 | int:RPL36AL | |
| Interaction | NCL interactions | ROCK2 GTPBP4 HK1 ACLY ECT2 LARP7 DNAJC2 CCNT1 MRPS7 SUZ12 USP48 DDX24 RPL19 | 1.58e-04 | 798 | 100 | 13 | int:NCL |
| Interaction | LHX1 interactions | 1.62e-04 | 103 | 100 | 5 | int:LHX1 | |
| Interaction | ACTC1 interactions | GTPBP4 ECT2 LARP7 CCNT1 DST SYNE2 TPX2 TTC17 SUZ12 USP48 GOLGB1 RPL19 | 1.66e-04 | 694 | 100 | 12 | int:ACTC1 |
| Interaction | PDZD2 interactions | 1.70e-04 | 22 | 100 | 3 | int:PDZD2 | |
| Interaction | RPL10 interactions | ROCK2 GTPBP4 MAP3K20 MRPL10 ECT2 LARP7 DNAJC2 MRPS7 LAS1L MAP2K1 DDX24 RPL19 | 1.85e-04 | 702 | 100 | 12 | int:RPL10 |
| Interaction | SRSF6 interactions | GTPBP4 ZBTB48 ECT2 LARP7 MRPS7 ZNF22 PRDM10 SUZ12 DDX24 RPL19 | 1.99e-04 | 503 | 100 | 10 | int:SRSF6 |
| Interaction | RPL23A interactions | GTPBP4 ZBTB48 ZNF317 ECT2 LARP7 DNAJC2 MRPS7 PRDM10 DST DDX24 RPL19 | 2.09e-04 | 606 | 100 | 11 | int:RPL23A |
| Interaction | ZFX interactions | 2.22e-04 | 24 | 100 | 3 | int:ZFX | |
| Interaction | ACSF3 interactions | 2.25e-04 | 60 | 100 | 4 | int:ACSF3 | |
| Interaction | NOP2 interactions | 2.26e-04 | 416 | 100 | 9 | int:NOP2 | |
| Interaction | RAB11A interactions | ROCK2 GTPBP4 HK1 ITGA6 ERBIN DST SYNE2 TPX2 EXOC6B OCIAD2 DDHD2 LRBA GOLGB1 | 2.32e-04 | 830 | 100 | 13 | int:RAB11A |
| Interaction | RPL3 interactions | GTPBP4 ZBTB48 ZNF317 ECT2 LARP7 DNAJC2 MRPS7 ZNF22 METTL18 USP48 DDX24 RPL19 | 2.39e-04 | 722 | 100 | 12 | int:RPL3 |
| Interaction | H1-7 interactions | 2.70e-04 | 179 | 100 | 6 | int:H1-7 | |
| Interaction | FCGRT interactions | 2.82e-04 | 116 | 100 | 5 | int:FCGRT | |
| Interaction | TERF2 interactions | 2.92e-04 | 340 | 100 | 8 | int:TERF2 | |
| Interaction | RPS14 interactions | 2.98e-04 | 529 | 100 | 10 | int:RPS14 | |
| Interaction | SMAD4 interactions | 3.03e-04 | 530 | 100 | 10 | int:SMAD4 | |
| Interaction | RPL6 interactions | ROCK2 GTPBP4 MRPL10 ECT2 LARP7 DNAJC2 CCNT1 MRPS7 DST DDX24 RPL19 | 3.20e-04 | 637 | 100 | 11 | int:RPL6 |
| Interaction | REXO4 interactions | 3.24e-04 | 261 | 100 | 7 | int:REXO4 | |
| Interaction | NPM3 interactions | 3.32e-04 | 262 | 100 | 7 | int:NPM3 | |
| Interaction | PNMA8A interactions | 3.56e-04 | 122 | 100 | 5 | int:PNMA8A | |
| Interaction | TRIM75 interactions | 3.61e-04 | 6 | 100 | 2 | int:TRIM75 | |
| Cytoband | 16p13.11 | 1.77e-05 | 23 | 101 | 3 | 16p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q31 | 4.89e-04 | 164 | 101 | 4 | chr4q31 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 HIVEP1 ZBTB48 ZNF780B ZBTB26 ZNF317 ZFX ZFY ZNF462 ZNF22 PRDM10 ZNF676 GTF3A ZNF827 ZNF80 SUZ12 ZNF99 | 6.62e-10 | 718 | 67 | 17 | 28 |
| GeneFamily | Sterile alpha motif domain containing | 1.85e-05 | 88 | 67 | 5 | 760 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 HIVEP1 SETX ITGA6 CLASP2 REV3L LARS2 ME2 CREB5 DNAJC2 DST SYNE2 SUZ12 BCAR3 MAP2K1 | 8.68e-07 | 856 | 100 | 15 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX ARHGAP10 PBK ITGA6 DYNC2I1 REV3L ECT2 LARP7 ZNF22 SYNE2 SUZ12 USP48 GOLGB1 | 1.30e-06 | 656 | 100 | 13 | M18979 |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 1.01e-05 | 195 | 100 | 7 | M3089 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.19e-05 | 200 | 100 | 7 | M9687 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN | 1.19e-05 | 200 | 100 | 7 | M4318 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.01e-05 | 300 | 100 | 8 | M8702 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | HK2 ACLY NPIPA1 ITGA6 SPATA20 REV3L ME2 DNAJC2 GTF3A SYNE2 MED7 USP48 | 4.79e-05 | 790 | 100 | 12 | M12490 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 5.95e-05 | 176 | 100 | 6 | M2981 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 7.48e-05 | 466 | 100 | 9 | M13522 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 SETX HK2 ACLY PBK DYNC2I1 REV3L LARS2 ME2 CREB5 LARP7 DNAJC2 ZNF462 ZNF22 SYNE2 TPX2 UBA6 SUZ12 | 1.58e-05 | 1257 | 98 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ROCK2 DOCK3 SETX HK2 ACLY PBK DYNC2I1 REV3L LARS2 ME2 CREB5 LARP7 DNAJC2 ZNF462 ZNF22 SYNE2 TPX2 UBA6 SUZ12 | 3.32e-05 | 1459 | 98 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 GTPBP4 SETX ZNF317 ME2 LARP7 DNAJC2 TPX2 UBA6 SFXN2 SUZ12 | 3.45e-05 | 532 | 98 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.97e-05 | 146 | 98 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.81e-08 | 199 | 101 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 173 | 101 | 7 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 173 | 101 | 7 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.61e-07 | 199 | 101 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.48e-06 | 188 | 101 | 6 | 2513ca0efa73c09a3406b99e2876982d78b173d7 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.21e-06 | 199 | 101 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 199 | 101 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.21e-06 | 199 | 101 | 6 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | severe-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.39e-06 | 200 | 101 | 6 | 61c7c08460856c188e62edf1fa62855578146fc8 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.58e-05 | 138 | 101 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | URO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type | 4.54e-05 | 172 | 101 | 5 | 97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.79e-05 | 174 | 101 | 5 | 5c69447261c5aa309a24882656da90655728d637 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 176 | 101 | 5 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-05 | 179 | 101 | 5 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.09e-05 | 183 | 101 | 5 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.41e-05 | 185 | 101 | 5 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.57e-05 | 186 | 101 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.27e-05 | 190 | 101 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.45e-05 | 191 | 101 | 5 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.64e-05 | 192 | 101 | 5 | 78546a6e077076834fd717607610ab6df3b6e7ba | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.82e-05 | 193 | 101 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 7.82e-05 | 193 | 101 | 5 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-05 | 193 | 101 | 5 | 192432ce2f8f95f8b8fa3812d311d35ee2b89f86 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 194 | 101 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.02e-05 | 194 | 101 | 5 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Severe / Disease group, lineage and cell class | 8.21e-05 | 195 | 101 | 5 | 658751e384de50cdcb907d3740fb1a74004a517b | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 8.21e-05 | 195 | 101 | 5 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-05 | 195 | 101 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.21e-05 | 195 | 101 | 5 | e3e5c784e7b494434fb4f6f27e0af22b167842ef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.21e-05 | 195 | 101 | 5 | d6b8bc4204476220a64afe17e3b6b2ed59853284 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | 459408882babf1fb56b37dc52ec119ac0b0153a7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.41e-05 | 196 | 101 | 5 | 768fce92bcf47734fa6c4a448f1266f34583fb41 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | ffc2728663a72ec62fa2e5b1054368fb56d18c62 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | a1a1e4e4404a0c590edd07dfc9e7e1b6f720fb0f | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 8.41e-05 | 196 | 101 | 5 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.62e-05 | 197 | 101 | 5 | 33d841f4fcff8aeb0b988d5dd072166347bc6022 | |
| ToppCell | COVID-19_Severe-CD4+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 8.62e-05 | 197 | 101 | 5 | 575494abe82de4924ac18cef4355c305e9a6481f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.62e-05 | 197 | 101 | 5 | 7f686353e1e08e0a0f721a6806c92d05254a77b2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.62e-05 | 197 | 101 | 5 | 442fb5ee17e6d4d8c280721b21fd3f7ba6475951 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.62e-05 | 197 | 101 | 5 | 4c928a4dde295bf220bcb0b2f30ca4a106b0e511 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.83e-05 | 198 | 101 | 5 | 0b9d3518d60d877e1423517fab374381bf678a2b | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 8.83e-05 | 198 | 101 | 5 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-05 | 198 | 101 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Caecum-T_cell-Tcm|T_cell / Region, Cell class and subclass | 8.83e-05 | 198 | 101 | 5 | f889ee80c641540fd8db9eaefcd16aa51ddb2c01 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.83e-05 | 198 | 101 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-05 | 199 | 101 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 199 | 101 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 9.04e-05 | 199 | 101 | 5 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-05 | 199 | 101 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-05 | 199 | 101 | 5 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 9.04e-05 | 199 | 101 | 5 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.04e-05 | 199 | 101 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-05 | 199 | 101 | 5 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-05 | 200 | 101 | 5 | 73b91cb66c375b44e852404a4a445cf2b9595aee | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_Tcm|COVID-19_Severe / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | b0073497dfd04d900d60e3ec7b8f2e8ae3ba02d1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK|COVID-19_Severe / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 323cb89add511fbe9896b4df0f1f2b7fdbb6c649 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK|COVID-19_Severe / Disease group, lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 9fc818bf5c9133fc2fece47980e71fd3f8603558 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.25e-05 | 200 | 101 | 5 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | severe-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | e83558090a079dd9e40e0d3b5d9917fbd2695ec4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-05 | 200 | 101 | 5 | f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.53e-04 | 135 | 101 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 139 | 101 | 4 | 7e2c10830c3d16109cab3ed0d64b3532481e497d | |
| ToppCell | Control-APC-like-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 3.15e-04 | 143 | 101 | 4 | ffc1f497245d559e97e40d1bc4ee14e1ef09040c | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.23e-04 | 144 | 101 | 4 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 146 | 101 | 4 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.68e-04 | 149 | 101 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.96e-04 | 152 | 101 | 4 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 4.06e-04 | 153 | 101 | 4 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-04 | 154 | 101 | 4 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-04 | 156 | 101 | 4 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.37e-04 | 156 | 101 | 4 | a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-04 | 158 | 101 | 4 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 159 | 101 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 159 | 101 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 4.92e-04 | 161 | 101 | 4 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_TEM|ICU-SEP / Disease, Lineage and Cell Type | 4.92e-04 | 161 | 101 | 4 | ae6c9afc3c928124993686a82d37d23138322bc1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.92e-04 | 161 | 101 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.04e-04 | 162 | 101 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-04 | 164 | 101 | 4 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 165 | 101 | 4 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.38e-05 | 50 | 67 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.37e-04 | 49 | 67 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.04e-06 | 191 | 100 | 8 | 7503_DN | |
| Disease | Speech Disorders | 6.13e-05 | 4 | 95 | 2 | C0037822 | |
| Disease | Global developmental delay | 7.22e-05 | 133 | 95 | 5 | C0557874 | |
| Disease | smoking status measurement, triglyceride measurement | 1.53e-04 | 6 | 95 | 2 | EFO_0004530, EFO_0006527 | |
| Disease | Paroxysmal atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.72e-04 | 160 | 95 | 5 | C0004238 | |
| Disease | Visual Impairment | 2.13e-04 | 7 | 95 | 2 | C3665347 | |
| Disease | Ataxias, Hereditary | 2.84e-04 | 8 | 95 | 2 | C0004138 | |
| Disease | Intellectual Disability | 6.14e-04 | 447 | 95 | 7 | C3714756 | |
| Disease | Metastatic melanoma | 7.12e-04 | 54 | 95 | 3 | C0278883 | |
| Disease | hair colour measurement | 8.44e-04 | 615 | 95 | 8 | EFO_0007822 | |
| Disease | cardioembolic stroke | 2.25e-03 | 170 | 95 | 4 | EFO_1001976 | |
| Disease | response to peginterferon alfa-2a | 2.93e-03 | 25 | 95 | 2 | EFO_0010103 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRHIEAKKLEKKHPQ | 1201 | Q96RT1 | |
| MHHAKIKELEDLKRT | 476 | Q7Z3E2 | |
| SKERHIMDRTPEKLK | 121 | O75815 | |
| QKSKKPLMVIHHLED | 56 | Q8TD06 | |
| RHVFDMKPKHLLSGK | 611 | Q9BZE4 | |
| DIPMTKKLLLHHANI | 161 | Q6NSI1 | |
| MGKIDKKALIRHFHP | 561 | Q4G176 | |
| KPEEIKMRIKVHAAA | 476 | O60563 | |
| HKAMVLKHHPDKRKA | 111 | Q99543 | |
| KMPSEIAKRNKHHEI | 216 | Q8WWH4 | |
| VKHFMKQHILPAEKE | 386 | Q709F0 | |
| KDIAKMRHHISVVKG | 431 | Q8IWA6 | |
| HILNMLHLKKRPDVT | 61 | P08476 | |
| REKHKIMHRDVKPSN | 181 | Q02750 | |
| IDLEHMRTIKPEKHL | 131 | P51157 | |
| IFMTLAHKLKSHKPL | 191 | Q9H082 | |
| RLALIERMLEKHHKP | 486 | Q96DM1 | |
| KTMDITVKGLKHPHR | 371 | O75916 | |
| SLKHIHLMPLSQIKK | 726 | Q9H8V3 | |
| GHHDRKAMKVKTPLR | 246 | Q86VS3 | |
| KLHIHRAEISKIMRE | 31 | Q56VL3 | |
| HLRKLSMKEREHGEK | 146 | Q9UND3 | |
| HFLVHKLPEKNKEML | 496 | A1A4S6 | |
| HRHKHEMTLKFPSIK | 36 | Q02930 | |
| PEMAAKLHPHDKRKV | 171 | Q9H3H1 | |
| LMPGAEKLIIHLRKH | 91 | Q08623 | |
| LIAEHKPHIDKMNKT | 5986 | Q03001 | |
| DHLTKKDLRVHLKMV | 976 | O75335 | |
| RLHPMQFDHKKELRK | 66 | O43513 | |
| HREKKLRKESEMDLP | 36 | Q8WVS4 | |
| KLHPHFAKVMHETVK | 866 | P52789 | |
| HPSDRPLMLAIHKKI | 371 | O15055 | |
| KVPPHMLRAHIKEIE | 966 | Q6ZWH5 | |
| MPKLFLHLEKKTPVH | 381 | Q8N5Y2 | |
| LIPHHKGRKRMHLEL | 561 | O94830 | |
| HAGKLLSVLKHMPQK | 186 | P50851 | |
| FLKHLAPKRKAEVML | 746 | P50851 | |
| KKHKERHKMGEEVIP | 361 | Q4G0J3 | |
| IVDLRHELTHKKMPH | 151 | Q9Y4W2 | |
| SLRAAKEHAMPKDLK | 96 | O95568 | |
| MKTKRHYPALKTLEH | 151 | Q9Y2D4 | |
| LKRDMKSAHLLPEHI | 331 | P23229 | |
| KTKMVQHIRKKHPEF | 846 | Q9NQV6 | |
| HLRKLSMKEREHGEK | 146 | F8WFD2 | |
| HFHLTKDMLLEVKKR | 476 | P19367 | |
| DMEKELGIKHPLHRK | 596 | Q8ND30 | |
| EKFVHPEMRPLHKKL | 1601 | Q8IZD9 | |
| MKDRHLVTKRLKEHI | 276 | Q53EU6 | |
| PKVTMKTGKSLLHLH | 321 | Q8NFQ5 | |
| LHMEAPVKVIHRDLK | 121 | Q9NYL2 | |
| CRHLHIKEKGKPLML | 16 | P23368 | |
| APARILHKKHTKKMD | 516 | Q9GZR7 | |
| ILHKVKSQKCPMLHH | 331 | Q96HH9 | |
| VLASHLKPLERKDKM | 51 | Q8IW40 | |
| EVELMKVARAHPKAK | 136 | P11926 | |
| LDHLTKKDLRVHLKM | 1051 | O75334 | |
| QGPVIKRKHDLHKMA | 216 | Q9Y2R9 | |
| EKLHFMQKVKVLHAP | 251 | Q96NB2 | |
| IKHFLRKIIMVHPKV | 126 | Q8N6T0 | |
| HALRPDLIDMKSVKH | 221 | Q8WXH0 | |
| QKMVKHREPFHKLLA | 581 | Q15031 | |
| HLRKLSMKEREHGEK | 146 | E9PKD4 | |
| PRTTVHKRMDHLKVK | 41 | Q1XH10 | |
| RILMEHIHKLKADKA | 136 | P84098 | |
| KELPSHVQAMHKRKE | 2071 | Q7Z333 | |
| PLKHSGHLMKTNLRK | 56 | Q01826 | |
| EEMILESRPLHKKKK | 386 | Q86UX6 | |
| KKHLLVHAPEDKKEI | 166 | P53396 | |
| MKTLEAHKDPHKEVV | 1146 | O75122 | |
| IKLSLLAHMERKHFP | 76 | Q537H7 | |
| KDLQSHMIKLHGAPK | 391 | P10074 | |
| HAKRLKLTMHKLVKP | 1001 | A0AVT1 | |
| LTVHKVIHMEEKPCK | 496 | A8MXY4 | |
| LDRLTKKLVHDMNHP | 256 | Q15654 | |
| IKEKYEHRMLLKHMP | 251 | Q5TCY1 | |
| SKLMEHKRIHTGEKP | 406 | Q8N7Q3 | |
| IRKIEKDSPFIHMHR | 681 | O60673 | |
| AEDKLLMRHQLRKHK | 106 | Q7Z7H8 | |
| ARKHRPKPHLDSKML | 491 | Q8TB22 | |
| VKKPKMEHVQADHEL | 71 | Q15022 | |
| DKTKELRKAMAPVHL | 26 | A2RTY3 | |
| KPDNMLLDKHGHLKL | 216 | O75116 | |
| CLKAIMKRVNHKVPH | 46 | O75886 | |
| RLMDEAKILKSLHHP | 81 | Q96KB5 | |
| KPFLTEKIKERIHMH | 211 | P49638 | |
| LKAKMPDDHARKILL | 576 | Q96AE7 | |
| TKLVRHQKIHMGEKP | 346 | Q9Y6R6 | |
| MKTPEQLLEHKKCHT | 1056 | Q17R98 | |
| LTRHMKIHTGEKPCK | 176 | P51504 | |
| HLRQHMKVHKEEKPR | 181 | P17026 | |
| SELKKHMRIHTGEKP | 561 | P17010 | |
| RKHIKKDHPALKATV | 1281 | Q96JM2 | |
| RHAVVHDPDKKKMKL | 296 | Q92664 | |
| HDKLHPDKISIMKRI | 516 | Q86UV5 | |
| RKHMRIHIVKKPVEC | 406 | Q96PQ6 | |
| RCKKPSMLKKHIRTH | 2096 | P15822 | |
| LIRRKIVKPKHHVLM | 431 | Q6P2D8 | |
| IVKPKHHVLMSRKES | 436 | Q6P2D8 | |
| MVFAHKPVLRKHLKQ | 361 | Q9HCK0 | |
| LKRHMKNHPEHLAKK | 436 | P08048 | |
| SALMKHKVIHTGEKP | 781 | A6NN14 | |
| HHVKMKAKRCATPVI | 136 | Q9ULW0 | |
| KKELKHLHHDAGIMR | 2681 | Q14789 | |
| IHDTPMLLHVRKVKD | 5491 | P20929 |